The Ritedose Corporation
The Ritedose Corporation
HOME
ABOUT US
MANUFACTURING
QUALITY
DEVELOPMENT
503B CONTACT US
News
CONTACT
Link Format
The Ritedose Corporation
>
Gallery
>
Link
Link Format
July 20, 2015
Continue reading
Link Format
July 20, 2015
Continue reading
Link Format
July 20, 2015
Continue reading
Recent Posts
Ritedose Launches New 503B, Single-Dose Syringe Medications for Hospitals:
Rocuronium Bromide Injection (50 mg/5mL) and Rocuronium Bromide Injection (100 mg/10mL)
The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser
SuredoseRx™ to launch in first quarter
Ritedose Pharmaceuticals Launches Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 ml
Novo Holdings to acquire Ritedose:
Novo Holdings A/S (“Novo Holdings”) today announced that it has agreed to acquire Ritedose from AGIC Capital and Humanwell.
Ritedose Pharmaceuticals Launches Budesonide Inhalation Suspension (0.5 mg/2 ml)
Recent Comments
Archives
February 2022
January 2022
December 2021
September 2021
August 2021
May 2021
April 2021
March 2021
November 2020
August 2020
March 2020
Categories
In the News
Press Releases
Uncategorized
Meta
Log in
Entries feed
Comments feed
WordPress.org
Recent News
Ritedose Launches New 503B, Single-Dose Syringe Medications for Hospitals:
Rocuronium Bromide Injection (50 mg/5mL) and Rocuronium Bromide Injection (100 mg/10mL)
Posted on 28th February, 2022
The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser
SuredoseRx™ to launch in first quarter
Posted on 18th January, 2022
Ritedose Pharmaceuticals Launches Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 ml
Posted on 5th January, 2022
Post Categories
In the News
(11)
Press Releases
(10)
Uncategorized
(8)
Search Posts
×
Your ticket for the: Link Format
Title
Link Format
USD
-
-
-
Recent Comments